Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 by admin June 4, 2025 June 4, 2025 Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com previous post 5 Biggest Blockchain ETFs in 2025 next post Adam Rozencwajg: Gold Stock Gains, Silver and Uranium Prices — Plus PGMs Bull Case You may also like Nickel Price Update: Q3 2025 in Review October 30, 2025 Lundin Mining Declares Filo del Sol a “Generational”... May 8, 2025 Editor’s Picks: Gold Faces Bumpy Week on Trade... June 1, 2025 Widespread Natural Rutile Observed Throughout the Central Rutile... June 11, 2025 Eric Nuttall: Oil vs. Natural Gas Stocks, Plus... May 15, 2025 Nevada Sunrise Closes $650,000 Private Placement November 7, 2025 Drill Rig Mobilised at Lo Herma ISR Uranium... October 15, 2025 Questcorp Mining Completes 25 Percent of Maiden Drilling... August 19, 2025 FinEx Metals July 2, 2025 MP Materials, US Department of Defense Strike Saudi... November 22, 2025